Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials

Bibliographic Details
Title: Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials
Authors: Dore, Gregory J., Conway, Brian, Luo, Yan, Janczewska, Ewa, Knysz, Brygida, Liu, Yan, Streinu-Cercel, Adrian, Caruntu, Florin Alexandru, Curescu, Manuela, Skoien, Richard, Ghesquiere, Wayne, Mazur, Włodzimierz, Soza, Alejandro, Fuster, Francisco, Greenbloom, Susan, Motoc, Adriana, Arama, Victoria, Shaw, David, Tornai, Istvan, Sasadeusz, Joseph, Dalgard, Olav, Sullivan, Danielle, Liu, Xuan, Kapoor, Mudra, Campbell, Andrew, Podsadecki, Thomas
Source: In Journal of Hepatology January 2016 64(1):19-28
Database: ScienceDirect
More Details
ISSN:01688278
DOI:10.1016/j.jhep.2015.08.015
Published in:Journal of Hepatology
Language:English